Optimizing patient care: minimizing the impact of chemotherapy-induced toxicities.
Research into reducing the side effects of anthracyclines and optimizing patient care and quality of life is constantly evolving. This program took a look at ways that oncology nurses can reduce the toxicities of conventional and novel chemotherapy regimens as well as addressing the erythropoietic agents used to treat patients with anemia.
D000740:Anemia / Q000139:chemically induced / Q000517:prevention & control; D018943:Anthracyclines / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D024802:Nurse's Role; D009859:Oncology Nursing / Q000458:organization & administration*; D005791:Patient Care / Q000523:psychology / Q000592:standards*; D011788:Quality of Life; D017749:Total Quality Management / Q000458:organization & administration*
D018943:Anthracyclines; D000970:Antineoplastic Agents; D006397:Hematinics; D004921:Erythropoietin